Novo Nordisk has announced that it's cutting the price of pre-filled insulin pens and vials by up to 75 percent for people living with diabetes starting in January 2024.
"We have been working to develop a sustainable path forward that balances patient affordability, market dynamics, and evolving policy changes," said Steve Albers, senior vice president of market access and public affairs at Novo Nordisk, Inc. "Novo Nordisk remains committed to ensuring patients living with diabetes can afford our insulins, a responsibility we take seriously."
Earlier this month, rival drugmaker Eli Lilly announced plans to reduce insulin prices by 70 percent and cap patient out-of-pocket costs for insulin at $35 per month.
The Biden administration has put public pressure on drugmakers to make medically necessary insulins more affordable. Novo Nordisk notably did not put a cap on out-of-pocket expenses.
Novo Nordisk will lower the price for four different brands, including NovoLog® and NovoLog® Mix 70/30 by 75 percent and Novolin® and Levemir® by 65 percent.
Beyond Meat reported that it failed to meet market expectations during its quarterly revenue report, as the company has faced weakening demand for its plant-based meat products.
Finding a new job is an emotional journey in itself and one woman is looking to get back into the workforce after some time off. Cheddar News' docuseries Ready 4 Work profiles her as she works through her job search.
Virgin Galactic has announced plans to pause flight operations next year so they can focus more on developing its next-generation delta class spacecraft.
